CBTBasic Materials · Specialty ChemicalsThe 6 Wall Street analysts covering Cabot Corp. hold a median 12-month price target of $88 — +21.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 76 of 100 as at 13 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Cabot Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (92): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Growth (26): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on CBT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +21.7% from it.
Of the 20 most recent actions, 2 moved their price target up and 5 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 10 Nov 2026 | JP Morgan | Maintains | Underweight | $78 → $68 |
| 4 Nov 2026 | Truist Securities | Maintains | Buy | $100 → $95 |
| 4 Nov 2026 | UBS | Maintains | Neutral | $86 → $80 |
| 5 Oct 2026 | UBS | Maintains | Neutral | — |
| 5 Oct 2026 | UBS | Maintains | Neutral | $92 → $86 |
| 7 Aug 2026 | JP Morgan | Maintains | Underweight | $70 → $78 |
| 7 Aug 2026 | JP Morgan | Maintains | Underweight | — |
| 5 Aug 2026 | UBS | Maintains | Neutral | $97 → $92 |
| 5 Aug 2026 | UBS | Maintains | Neutral | — |
| 25 June 2026 | Mizuho | Maintains | Neutral | — |
| 25 June 2026 | Mizuho | Maintains | Neutral | $80 → $90 |
| 8 June 2026 | Truist Securities | Initiates | Buy | — |
| 13 May 2026 | JP Morgan | Maintains | Underweight | — |
| 8 May 2026 | UBS | Maintains | Neutral | — |
| 6 May 2026 | Mizuho | Maintains | Neutral | — |
| 5 Feb 2026 | Mizuho | Downgrade | Neutral | — |
| 5 Feb 2026 | UBS | Maintains | Neutral | — |
| 12 Jan 2026 | UBS | Maintains | Neutral | — |
| 18 Dec 2025 | Mizuho | Maintains | Outperform | — |
| 28 Nov 2025 | JP Morgan | Maintains | Underweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
CBT appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 13 Nov 2026, Cabot Corp. returned +18.4% against +13.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 40% of US stocks
Cheaper than 68% of US stocks
Cheaper than 38% of US stocks
Cheaper than 49% of US stocks
Higher than 58% of US stocks
Higher than 76% of US stocks
Higher than 19% of US stocks
Higher than 74% of US stocks
Higher than 61% of US stocks
Higher than 72% of US stocks
Higher than 90% of US stocks
Higher than 84% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Cabot Corp. has a market value of $3.7B and an enterprise value of $4.8B.
Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter grew 12.2% year on year.
Net income over the same four quarters: $228.0M, a 6.3% net margin.
Diluted earnings per share, trailing twelve months: $3.55.
Free cash flow in the twelve months to 30 June 2026: $281.0M.
Cabot Corp. spent $140.0M on share buybacks and $97.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 17.9×; forward P/E: 9.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.63%, paying out 51% of earnings.
Cabot Corp. employs 4,064 people — $894K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Cabot Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Cabot's fourth-quarter earnings beat estimates as growth in Performance Chemicals offset pressure in Reinforcement Materials. The company projected fiscal 2027 adjusted EPS of $6.15-$6.75.
Why it matters — The results highlight mixed performance across Cabot's businesses and include its fiscal 2027 adjusted EPS projection.
Cabot reported fourth-quarter fiscal 2026 adjusted EPS of $1.61, with strong Performance Chemicals results partly offsetting lower earnings in Reinforcement Materials. Full-year adjusted EPS was $6.42; operating cash flow was $421 million, and $243 million was returned to shareholders through dividends and repurchases.
Why it matters — The results highlight performance differences between Cabot’s business segments and provide full-year earnings, cash-flow, and shareholder-return figures for CBT watchers.
Cabot Corporation held its Q4 2026 earnings call on November 3, 2026. The excerpt lists company representatives and conference-call participants but provides no discussion of results or outlook.
Why it matters — The transcript identifies the participants in CBT’s earnings call, but the supplied excerpt contains no financial or operating details for investors to assess.
Cabot reported quarterly earnings of $1.61 per share, above the Zacks Consensus Estimate of $1.55. Earnings were $1.70 per share a year ago.
Why it matters — The results give CBT watchers an update on quarterly earnings compared with analyst consensus and the year-ago period.
Cabot reported fourth-quarter fiscal 2026 diluted EPS of $1.25 and adjusted EPS of $1.61; full-year diluted EPS was $4.02 and adjusted EPS was $6.42. Fiscal-year cash from operations was $421 million, and the company reported segment EBIT, Battery Materials EBITDA, and a $50 million U.S. Department of Energy grant agreement for battery-additive production expansion.
Why it matters — The results provide CBT watchers with full-year earnings and cash-flow figures, segment performance, and an update on planned domestic battery-materials production expansion.
The 6 Wall Street analysts covering Cabot Corp. have a median 12-month price target of $88, with estimates ranging from $68 to $95. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Cabot Corp., 2 rate it a Buy, 3 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Cabot Corp. 76 out of 100 across roughly 4,600 US stocks as at 13 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Nov 2026, Cabot Corp. ranks 76 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (92 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +21.7% from the last close, and Ticker Nerd's factor model ranks Cabot Corp. 76 out of 100 as at 13 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Cabot Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CBT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $68 to $95 over the next 12 months.
Cabot Corp. returned +18.4% over the 12 months to 13 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications.
The most recent item we track (Zacks Investment Research, 6 Nov 2026): "Cabot Q4 Earnings Beat on Performance Chemicals Strength". Cabot's fourth-quarter earnings beat estimates as growth in Performance Chemicals offset pressure in Reinforcement Materials. The company projected fiscal 2027 adjusted EPS of $6.15-$6.75.
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications. Its core offerings include reinforcing carbons, engineered elastomer composites, specialty carbons, conductive additives, battery materials, fumed metal oxides, masterbatches, conductive compounds, inkjet colorants, and aerogel. The company serves customers that rely on high-performance materials to improve durability, conductivity, reinforcement, dispersion, and insulation in finished products and manufacturing processes. Cabot Corporation operates through the Reinforcement Materials and Performance Chemicals segments, giving it exposure to both large-volume industrial markets and more specialized performance applications. With a focus on materials science and formulation expertise, Cabot Corporation plays an important role in supplying components that enhance product performance across multiple end markets.
CEO Ms. Erica J. McLaughlin CPA · 4,064 employees · United States · https://www.cabotcorp.com
